Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 202
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100MG/25MG/200MG TBL FLM 30
0234548 27/ 007/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100MG/25MG/200MG TBL FLM 100
0234549 27/ 007/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100MG/25MG/200MG TBL FLM 30
0234550 27/ 007/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100MG/25MG/200MG TBL FLM 100
0234551 27/ 007/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150MG/37,5MG/200MG TBL FLM 30
0234552 27/ 008/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150MG/37,5MG/200MG TBL FLM 100
0234553 27/ 008/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150MG/37,5MG/200MG TBL FLM 30
0234554 27/ 008/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150MG/37,5MG/200MG TBL FLM 100
0234555 27/ 008/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 200MG/50MG/200MG TBL FLM 30
0234556 27/ 009/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 200MG/50MG/200MG TBL FLM 100
0234557 27/ 009/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 175MG/43,75MG/200MG TBL FLM 10
0194395 EU/1/11/706/034 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 175MG/43,75MG/200MG TBL FLM 175
0194399 EU/1/11/706/038 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 175MG/43,75MG/200MG TBL FLM 100
0194397 EU/1/11/706/036 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 175MG/43,75MG/200MG TBL FLM 130
0194398 EU/1/11/706/037 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 50MG/12,5MG/200MG TBL FLM 250
0168693 EU/1/11/706/006 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 75MG/18,75MG/200MG TBL FLM 10
0168694 EU/1/11/706/007 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 75MG/18,75MG/200MG TBL FLM 30
0168695 EU/1/11/706/008 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 100MG/25MG/200MG TBL FLM 30
0168700 EU/1/11/706/013 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 100MG/25MG/200MG TBL FLM 100
0168701 EU/1/11/706/014 levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE ORION 100MG/25MG/200MG TBL FLM 130
0168702 EU/1/11/706/015 levodopaca.pdf levodopaca.pdf N04BA03 R

‹‹ ‹ 1 2 3 4 5 6 7 8 9 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 20. April 2021 at 01:09
Last update of price and payment data: 8. April 2021 at 01:09